hydroxychloroquine has been researched along with Rhinitis, Allergic, Seasonal in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Rhinitis, Allergic, Seasonal: Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonzano, L | 1 |
| Cassone, G | 1 |
| Tarallo, L | 1 |
| Pellacani, G | 1 |
1 other study available for hydroxychloroquine and Rhinitis, Allergic, Seasonal
| Article | Year |
|---|---|
The Rediscovery of Hydroxychloroquine in Allergic Diseases in the COVID-19 Era.
Topics: Adult; Anti-Allergic Agents; Antiviral Agents; Conjunctivitis, Allergic; COVID-19; COVID-19 Drug Tre | 2021 |